Results 111 to 120 of about 19,741 (164)

Erratum for the Research Article "Biointerface mineralization generates ultraresistant gut microbes as oral biotherapeutics" by Z. Geng <i>et al</i>.

Sci Adv
europepmc   +1 more source

IgY Antibodies as Biotherapeutics in Biomedicine

Antibodies, 2022
Since the discovery of antibodies by Emil Von Behring and Shibasaburo Kitasato during the 19th century, their potential for use as biotechnological reagents has been exploited in different fields, such as basic and applied research, diagnosis, and the treatment of multiple diseases.
Dolores Correa, Magdalena Escorcia, Fernando Gómez-Chávez   +2 more
exaly   +4 more sources

Nanogels for intracellular delivery of biotherapeutics

Journal of Controlled Release, 2017
Many biomolecules, such as proteins and genes, are presently used as therapeutics. However, their delivery to target sites inside cells is challenging because of their large molecular size, difficulties to pass cellular membranes and their susceptibility for enzymatic and chemical degradation.
Wim Hennink, Tina Vermonden, Enrico Mastrobattista   +2 more
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Biotherapeutics

Drug News & Perspectives, 2008
This Society for Medicines Research symposium was held on March 6, 2008, at the National Heart and Lung Institute, London, U.K. The meeting, organized by Kate Brown and David Fox reviewed the state-of-the-art in biotherapeutics. This is an area that is acquiring increasing importance in drug discovery and development portfolios, offering new and ...
Katherine, Brown, David, Fox
openaire   +2 more sources

Liposomes and biotherapeutics

Biotherapy, 1991
Application of liposomes as delivery system for biotherapeutic peptides and proteins may offer important therapeutic advantages over existing delivery methods. Several approaches towards achieving improved delivery of biotherapeutics with liposomes are outlined.
G, Storm, H P, Wilms, D J, Crommelin
openaire   +2 more sources

Biotherapeutic Approaches in Atopic Dermatitis

Biotechnology Journal, 2020
AbstractThe skin microbiome plays a central role in inflammatory skin disorders such as atopic dermatitis (AD). In AD patients, an imbalance between pathogenic Staphylococcus aureus (S. aureus) and resident skin symbionts creates a state of dysbiosis which induces immune dysregulation and impairs skin barrier function.
Elizabeth Huiwen Tham, Elvin Koh, John E. A. Common, In Young Hwang   +3 more
openaire   +2 more sources

Live bacterial biotherapeutics in the clinic

Nature Biotechnology, 2018
International ...
Bermudez-Humaran, Luis G., Langella, Philippe   +1 more
openaire   +3 more sources

Differentiating biosimilarity and comparability in biotherapeutics

Clinical Rheumatology, 2016
The manufacture of biologics is a complex process involving numerous steps. Over time, differences may arise as a result of planned changes to the manufacturing processes of a biologic from the same manufacturer. Comparability is the regulatory process that outlines the scope of an assessment required of an already licensed biologic after a ...
Valderilio, Azevedo, Brian, Hassett, João Eurico, Fonseca, Tatsuya, Atsumi, Javier, Coindreau, Ira, Jacobs, Ehab, Mahgoub, Julie, O'Brien, Ena, Singh, Steven, Vicik, Brian, Fitzpatrick   +10 more
openaire   +2 more sources